FREMONT, Calif.,
August 23, 2021 (Newswire.com) –
Q’Apel Medical, Inc., an progressive neurovascular firm specializing in growing and commercializing novel entry system know-how for vascular interventions, introduced as we speak the launch of the Armadillo Radial Entry System, the newest software of the SelectFlex™ know-how and a part of the SelectFlex™Household of Neurovascular entry programs. The Armadillo Radial Entry System addresses the wants of each physicians and sufferers in a rising pattern to maneuver from femoral artery entry to radial artery entry. Radial artery entry has been the popular methodology of entry in cardiovascular procedures for many years sighting improved security profiles and elevated consolation for sufferers. Because the demand for radial artery entry in neurovascular procedures will increase, Q’Apel has positioned itself to prepared the ground. Armadillo is a radial platform of entry catheters particularly designed to handle the wants and challenges of radial entry.
“Extra Neurointerventionalists are changing to TRA as a result of security profile of any such entry and affected person satisfaction,” stated Pascal M. Jabbour MD, FAANS, FAHA, Distinguished Professor of Neurological Surgical procedure at Thomas Jefferson College Hospital Philadelphia.
“With the launch of Armadillo, we discover ourselves on the forefront of technological improvements that may carry a paradigm shift within the neurovascular trade. At Q’Apel, all the things comes again to the clinicians we serve. From our earliest beginnings, we’ve got constructed instruments not merely out of curiosity however out of demand. Now we have seen and heard the shortcomings medical doctors face with different merchandise on the market—and we’re exceptionally centered on creating options that work,” stated King Nelson, CEO of Q’Apel Medical.
“The Armadillo radial platform was designed to do extra with much less. It presents steady entry with fewer catheters and a decrease profile than a typical 8F Tri-Axial setup. The important thing options and advantages of this design will help make a difficult case simpler,” says Jeff Krolik, CTO of Q’Apel Medical.
Q’Apel Medical merchandise are already being utilized in over 185 hospital programs nationwide. Q’Apel is within the strategy of considerably rising its manufacturing capability and only in the near past introduced shifting right into a 35,000 sq. foot facility to accommodate the expansion. As well as, the corporate is within the strategy of buying CE certification, which is able to permit Q’Apel to increase into Europe later this yr.
About Q’Apel Medical:
Q’Apel Medical leverages extremely progressive applied sciences to assist physicians overcome their challenges regarding the supply of profitable neurovascular procedures. The corporate’s portfolio includes two core merchandise, the Walrus Balloon Information Catheter (BGC) system, and the Wahoo Management™ Catheter hybrid entry system. Q’Apel’s Walrus BGC is particularly designed to help medical doctors in performing mechanical thrombectomy procedures on stroke sufferers. In contrast to current balloon information catheter merchandise, the Walrus BGC has unmatched trackability, in addition to a bigger lumen which permits for the supply of advanced therapies and enormous bore stroke aspiration catheters. The Wahoo Management™ Catheter is a dual-mode hybrid entry system, offering two distinct operational modes – Monitoring Mode and Help Mode. The doctor controls the change of modes at any given second throughout a medical case. The hybrid nature of Wahoo reduces the necessity for a number of catheters in difficult procedures.
Media Contact: Q’Apel Medical
510.738.6255
www.qapelmedical.com
Supply: Q’Apel Medical, Inc.